You searched for prostate cancer | Page 28 of 130

Biomarker HSD3B1 Identified as Reason for Therapeutic Resistance

Posted by Chris Wolski | Nov 22, 2023 | Prostate |

Men with biomarker HSD3B1 may exhibit resistance to combined radiation and hormone therapy for prostate cancer.

Posted by Chris Wolski | Nov 15, 2023 | Cancer |

Timely cancer detection paves the way for interventions that are less toxic, less disruptive, and less costly than treatment in later stages.

Quest Mobile is a service designed to make it easier and more convenient for patients to have a specimen collected for lab testing nationwide.

Veracyte and Illumina will develop high-performing molecular tests as decentralized IVD tests on Illumina’s NextSeq 550Dx NGS instrument.

Posted by Andy Lundin | Nov 6, 2023 | Prostate |

Black men are more likely to develop prostate cancer than white men and more likely to have advanced disease and to die than white men.